Transcript Highlights:

• It feels like a regulation, not a law to me.
• the ownership, operations, or otherwise regulating drones.
• This bill will short-circuit... ...users like data centers.
• Some of them are furious about the data center going up from here to that wall, from a house to the data
• They not only regulate the pharmacists and the pharmacies, they also regulate pharmaceutical manufacturers

Summary: The committee approved the minutes and then heard several bills. HB 2686, sponsored by Rep. Heap, would require physicians performing surgeries at outpatient surgical facilities to annually and whenever changed provide the facility a call-coverage plan, including hospital coverage if applicable, to ensure patients have a known physician contact for complications; it passed 6-0 with one not voting. HB 2051 would require AHCCCS contractors, subject to CMS approval, to cover breastfeeding and lactation services in inpatient, outpatient, home-based, and group settings; supporters described the bill as improving maternal and infant health and AHCCCS said it was neutral with an estimated $1.8 million general fund cost, and it passed 6-0 with one not voting. HB 2837, a transparency bill for municipal zoning hearings, would require speakers to disclose compensation for testimony and require certain board members or hearing officers to disclose and recuse for recent ties to entities appearing before them; it passed 6-0 with one not voting. The committee also approved HB 2875, as amended, which clarifies local authority over commercial drone delivery systems and related land-use and zoning issues, including near airports; Zipline and industry supporters backed the bill as providing regulatory clarity, and it passed 6-0 with one not voting after adoption of the amendment. HB 2324 would let cities with their own fire codes, through an intergovernmental agreement, enforce those codes on county-owned buildings in city limits, with reporting requirements to the State Fire Marshal; county and fire-management representatives supported the measure as a clarification of jurisdiction, and it passed 6-0 with one not voting. HB 2439 would exempt single-user public or semi-public cold plunges from ADEQ pool rules, but the committee adopted an amendment removing ADEQ rulemaking authority; supporters said the bill would reduce confusion and regulatory burden, while one senator opposed it over public-health concerns, and it passed 4-2 with one not voting. HB 2457 would allow utilities to build certain co-located power plants without a certificate of environmental compatibility after notice and a public comment session, which opponents said would reduce public review and transparency for power plant siting, while supporters said it would streamline power development; it passed 4-2 with one not voting. Finally, HB 2953 would cap certain nondisciplinary and disciplinary civil penalties imposed by the State Board of Pharmacy at $25,000 in specified circumstances; a supporter said it matched limits used elsewhere and gave the board authority to use nondisciplinary actions, and it passed 6-0 with one not voting. The committee then adjourned.

Transcript Highlights:

• It was simply to recognize that we have data.
• But that data sharing is important.
• would suggest because the data is not reliable.
• So I'm not going to get into too many data points on that, although I do have all the DOH data.
• I'm not sure that, and I know you didn't mean that as actual data. I don't have that data.

Keywords: 996, all

Transcript Highlights:

• </c> to be regulated in this circumstance? to be regulated in this circumstance?
• </c> any new systems or new personal data. any new systems or new personal data.
• </c> excessive data collection or sales. excessive data collection or sales.
• </c> is the data sharing and selling. Okay? is the data sharing and selling. Okay?
• All personal data that's concerning a child is considered sensitive data.

Keywords: 1189, house, all

Transcript Highlights:

• I'd like to begin by sharing some of our data on... ...I'd like to begin by sharing some of our data
• And do we have any of that data? Is there any of that data beginning to be gathered?
• Do we have any of that data? Is there any of that data beginning to be gathered?
• I mean, is this data that new?
• I mean, is this data that new?

Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful for consumption, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. The hearing was framed as part of ongoing legislative work, including a future review of AB 1088, and members emphasized the need to weigh potential benefits against risks and consider whether stronger safeguards are needed. Expert testimony from a toxicology professor and several public health and medical officials described kratom as a plant with multiple alkaloids, with 7-OH identified as the more potent opioid-like compound associated with tolerance, dependence, withdrawal, and respiratory depression. CDPH reported 362 kratom-related overdose deaths in California from 2019 to 2023 and 15 deaths involving 7-OH, while Los Angeles County officials described unexplained deaths in young adults that led them to expand toxicology testing and identify 7-OH as a common factor. County and state public health representatives said they have issued advisories, contacted retailers, removed products from shelves, and taken enforcement actions, but they stressed that local enforcement is patchy, under-resourced, and limited by unclear jurisdiction and lack of testing capacity. Medical witnesses said patients are presenting with 7-OH dependence and withdrawal in ways similar to fentanyl-related cases, sometimes requiring buprenorphine, methadone, or repeated naloxone. They argued that unregulated retail sales and misleading marketing make the products especially risky, and that a statewide framework would be more effective than a patchwork of local ordinances. Some officials said the safest current policy is to keep kratom and 7-OH unlawful for consumption, while others said any new regulation would need resources, packaging rules, and clearer authority for enforcement. Industry and consumer advocates urged the committee to distinguish natural kratom leaf from concentrated or synthetic 7-OH products. They argued that kratom leaf has long-standing use, that 7-OH should be targeted rather than the whole plant, and that regulation should focus on age limits, labeling, testing, serving-size caps, and restrictions on adulterated products rather than prohibition. Several speakers warned that bans could push demand to the black market and reduce access for people using the products for pain relief or harm reduction, while critics of the industry said the products are being marketed deceptively and that more comprehensive regulation is needed.

Transcript Highlights:

• . least regulate.
• We heavily regulate ourselves because nobody is regulating us.
• We heavily regulate ourselves because nobody is regulating us.
• We heavily regulate ourselves because nobody is regulating us.
• ><c> regulating</c><03:27:24.479><c> um</c><03:27:24.720><c> an</c> currently um regulating regulating

Keywords: 1191, senate, all

Transcript Highlights:

• Next, making sense of health data. Healthcare generates tremendous amounts of data.
• And so bringing these data sets to the individual... like those kinds of insights are locked in our data
• We just need to have their data.
• That's 288 data points per day.
• is billions of data points.

Keywords: 988, house, all

Transcript Highlights:

• labeling and data largely on data labeling and data privacy<00:04:04.000><c> issues</c><00:04:04.480
• And so this data can to create new data.
• </c> training data. training data.
• Regulation then followed in the form of the Data Practices Act and, prior to that, the Data Privacy Act
• ><c> in</c><00:10:13.760><c> the</c> data. regulation then followed in the data. regulation then followed

Keywords: 1187, senate, all

Transcript Highlights:

• Because HMIS is federally regulated, we cannot mandate additional data elements to be collected.
• Because HMIS is federally regulated, we cannot mandate additional data elements to be collected.
• We have to follow based on the current statutes and regulations.
• You heard the data here today.
• So in terms of data non-disclosure, the trailer-bill language requires appropriate data non-disclosure

Keywords: 988, house, all

Transcript Highlights:

• kratom products and regulating 7-OH.
• And do we have any of that data? Is there any of that data beginning to be gathered?
• Do we have any of that data? Is there any of that data beginning to be gathered?
• I mean, is this data that new?
• I mean, is this data that new?

Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. Members referenced AB 1088, which would be considered later, and said the hearing was intended to clarify the science, medical perspective, and whether stronger safeguards are needed. The first panel featured a toxicology expert, state and local public health officials, an emergency/addiction physician, a medical examiner, and county health representatives. Witnesses from CDPH and Los Angeles County described rising deaths and enforcement actions, including statewide advisories, retailer letters, and product removals from manufacturers, wholesalers, and retailers. Medical testimony emphasized that 7-OH acts much more like an opioid than traditional kratom leaf, can cause dependence, withdrawal, and respiratory depression, and may require naloxone, buprenorphine, or methadone in overdose or withdrawal cases. Local officials said enforcement is difficult because packaging is inconsistent, testing capacity is limited, and counties lack resources and statewide infrastructure; they generally favored a centralized state framework if regulation is pursued. Committee members asked about testing, age restrictions, scheduling, and whether a distinction between kratom and 7-OH could be enforced. Witnesses said forensic labs can potentially test for 7-OH but validated assays are not routine, emergency departments cannot readily distinguish exposures, and local health departments do not have the lab capacity to verify product labels. Several officials warned that a ban or abrupt scheduling could push products into the black market and discourage research, while others argued that current prohibition and enforcement are the most protective approach because legalization or age-limited regulation could create confusion about legality and safety. The second panel included kratom and 7-OH advocates and industry representatives, who argued that natural kratom leaf and concentrated or synthetic 7-OH are different products and should be regulated differently. They supported age-gating, labeling, testing, and packaging rules for kratom leaf while opposing a ban on the botanical. They said 7-OH is used by many adults for pain relief or harm reduction, and that prohibition would drive consumers to illicit markets and worsen harm. Committee members pressed them on whether 7-OH is more potent than kratom, the availability of testing, and whether any safe dose is known. The hearing ended without a vote or formal action, with the chair noting the issue will continue to be considered in future legislation.

Transcript Highlights:

• links to the regulations.
• ,</c><00:03:41.920><c> everyone</c> administrative regulations, everyone administrative regulations,
• It's up-to-date data.
• It's up-to-date data. All standardized. It's up-to-date data.
• </c> a half years of continuous regulation. a half years of continuous regulation.

Keywords: 958, all

Summary: The committee first approved the minutes and then approved an agency amendment to a health and family services regulation. The amendment reversed a prior change so that neonatal ICU beds would remain subject to regular review rather than nonsubstantive review. The remaining administrative regulations were then reviewed without objection. The main presentation was from State Auditor Allison Ball on a report finding $836 million in concurrent Medicaid capitation payments from 2019 through 2022, involving individuals enrolled in Kentucky and at least one other state. Ball said Kentucky relied on the PARIS system, which has limitations because it is updated quarterly and depends on voluntary state participation, while a better federal data source, T-MSIS, was not fully available to the state. She said the audit found weak internal controls, siloed processes, outdated guidance, and a low-priority attitude toward residency checks, all of which contributed to missed alerts and improper payments. She also said the report identified additional problems, including payments made after beneficiaries died and cases involving multiple states paying for the same person. Ball recommended better access to federal data, stronger MCO contract provisions, and more active oversight by the Department for Medicaid Services and managed care organizations. She said the contracts reviewed did not provide a clear way to recoup the improper payments, though she and her counsel suggested possible equitable legal theories might be explored. Members expressed concern about the scale of the waste and the lack of contract enforcement, and asked whether any money could be recovered. Ball said the audit did not identify a clear contractual path to recoup the funds.

Transcript Highlights:

• That's very clear in the data.
• That's really for the regulators. That's really for the regulators.
• I will actually add one more thing on the data problem: the 1322 data, and I use this phrase so seldomly
• Finally, gasoline regulation—updating gasoline regulations—I think can help in the short term with a
• Those resupply regulations and minimum inventory regulations could have helped consumers at the pump

Summary: The Assembly Committee on Utilities and Energy held a hearing on the impact of the Iran conflict and global oil supply disruption on California fuel markets. Committee members and administration witnesses from the California Energy Commission and the Division of Petroleum Market Oversight described California’s heavy reliance on imported crude and refined products, the state’s shrinking refining base, current inventory levels, and how global supply tightness is affecting gasoline, diesel, and jet fuel prices. CEC officials said near-term supply looked adequate for roughly the next six weeks, but warned that continued disruption would likely raise prices further and increase competition for imports. DPMO said the conflict is a real supply shock, but also emphasized a separate, longstanding problem of unusually high California retail gasoline prices, especially among major branded stations. Witnesses and members debated the causes of high prices and the state’s longer-term fuel strategy. Professor Severin Borenstein argued that much of the price gap beyond taxes and environmental costs comes from a “mystery gasoline surcharge” downstream of refineries, while also noting that California’s shrinking number of refineries creates market-power and supply-resilience concerns. Western States Petroleum Association CEO Jody Mueller argued that state policies have weakened California’s refining system and made it more vulnerable to global shocks, urging the state to protect remaining refining capacity and improve infrastructure for imports. United Steelworkers Local 675 Vice President Norman Rogers stressed the need for safe, reliable refinery operations and adequate staffing. Several members pressed witnesses on whether California should rely more on imports, how to manage inventories and port/storage capacity, and whether the state needs clearer authority and better data collection to coordinate fuel policy. Discussion also covered branded versus unbranded gasoline pricing, the role of California fuel specifications, and whether a floating gas tax or other policy tools could buffer consumers from global price spikes. No formal votes or committee actions were taken during the hearing.

Transcript Highlights:

• So don't you think we need more data, or help me with that? Mr.
• That data will continue to be collected. We'll be continue to be tracking that.
• We'll continue to have the ability to have that data.
• Chair, Representative Scraba, we note those data. So we track that data.
• That we lose when we add more mandates and regulations, we stifle innovation.

Keywords: 1183, house

Transcript Highlights:

• that you have that data to back it up so members can see. a bunch of data, that you have that data to
• have no money to go toward regulating this.
• They have no money to go toward regulating this.
• data center developers' profits.
• We're now one of the top destinations for data centers.

Summary: The committee took up a series of Senate bills, beginning with SB 1421, a contentious measure restricting financial institutions and check cashers from accepting certain identification from unauthorized immigrants and limiting remittance transfers without proof of lawful status. An attempted strike-everything amendment by Rep. Villegas would have redirected the bill to authorize tax-deeded property sales for affordable housing, but the committee rejected that amendment. After public testimony both for and against the underlying bill, the committee voted 6-2 to give SB 1421 a due pass recommendation. The committee then approved SB 1254, which revises Industrial Commission of Arizona statutes, including renaming certain positions, shifting boiler and elevator oversight, and requiring fee schedules to be posted online. It also passed SB 1515, which creates a public safety parity fund for retention pay and benefits for DPS and corrections employees using investment earnings from the budget stabilization fund; supporters cited vacancies, turnover, and pay gaps, while opponents argued the state should fund raises through the general fund. Both bills received due pass recommendations after amendment adoption and roll call votes. Other measures considered included SB 1206, which restricts adjusters and contractors from soliciting work during active loss events or emergency responses, with an exception for essential services; SB 1563, which continues the Barbering and Cosmetology Board and lowers certain fee caps; and SB 1649, which creates a digital assets reserve fund, though an amendment to turn it into a transparency measure on employers receiving public assistance was rejected. The committee also passed SB 1290 after rejecting an amendment on emergency price controls and adopting a Carter amendment clarifying HOA executive sessions may be closed only for discussion without action; testimony on that bill focused heavily on HOA transparency versus privacy concerns. Finally, the committee approved SB 1670, a contractor licensing preemption bill, and SB 1671, which continues the Department of Gaming and related commissions and updates reporting and conflict-of-interest requirements, with the department supporting the continuation and amendment language.

Transcript Highlights:

• currently nuclear and who might be regulating. the state regulates currently nuclear and who might be
• When we looked at how the regulations, we looked at how the regulations... And such.
• When we looked at how the regulations come about is after the Nuclear Regulatory Commission revises regulations
• , there comes up with new regulations.
• of the regulations that North Dakota has adopted by regulation...

Summary: The committee met to review advanced nuclear energy issues in North Dakota, beginning with approval of the April 21, 2022 minutes. Nucleon presented an overview of the advanced reactor landscape, distinguishing light-water SMRs, advanced Gen 4 reactors, and microreactors. The presentation emphasized that light-water SMRs are the most near-term deployable and use familiar low-enriched uranium fuel, while many Gen 4 designs may require high-assay low-enriched uranium (HALU), which is not yet supported by a mature U.S. supply chain. Nucleon also noted that advanced reactors are being developed primarily for industrial heat applications, while microreactors are niche, higher-cost systems for remote or mission-critical uses. Committee members asked about fuel availability, safety, recycling, and whether large reactors such as AP-1000s were evaluated; the presenter said fuel development is proceeding in parallel but remains a bottleneck, and that siting and grid capacity often make SMRs more practical than gigawatt-scale plants in North Dakota. Representatives from the National Association of State Energy Officials described how other states are supporting advanced nuclear through task forces, roadmaps, regional coordination, grants, tax incentives, workforce and supply-chain efforts, and pilot programs. They highlighted the Advanced Nuclear First Mover Initiative and said states are focusing on multi-state coordination, demand aggregation, regulatory coordination, waste management, workforce readiness, and community engagement. They also discussed affordability tools such as construction work in progress (CWIP), financing incentives, and consumer protections, citing examples from Kentucky, Texas, Virginia, Illinois, Missouri, Utah, Tennessee, and others. In response to questions, they explained that pilot programs often involve site-readiness and feasibility studies, and that the federal Nuclear Innovation Campus process is moving forward with multiple submissions while broader waste and recycling policy may require congressional action. The Public Service Commission said it would likely have a major role in any North Dakota nuclear project through certificate-of-public-convenience-and-necessity review, siting, and rate regulation, but noted gaps in current law for small reactors, co-located facilities, NRC coordination, and long-term site stewardship. The commissioner said the commission has no authority over a private, self-contained reactor not connected to the grid. The Department of Environmental Quality explained that the state regulates radioactive materials under its agreement-state authority, but NRC retains primacy over fission reactors; DEQ would likely assist with emergency planning and could have a larger role if fusion reactors emerge. The Department of Emergency Services said it would serve as the lead off-site preparedness agency, requiring a dedicated radiological emergency preparedness program, training, drills, public outreach, and likely additional funding and staffing, with industry expected to bear much of the cost. The Department of Water Resources said North Dakota’s water laws and prior-appropriation system are adequate for nuclear siting, that the Missouri River is the best likely source, and that no statutory or budget changes are currently needed from a water perspective. The committee recessed for lunch after these agency presentations.

Transcript Highlights:

• The regulator oversight is critical.
• Separately, I also think it's really important for the regulator to be able to provide comparative data
• , up-to-date data about differences, Sorry, for the regulator to be able to provide comparative data,
• up-to-date data about different CCRCs.
• And I circled, “We need to strengthen our regulator insight.”

Keywords: 995, all

Summary: The commission’s fifth meeting focused on consumer protections and resident rights in continuing care retirement communities (CCRCs), with a presentation by Yvonne Choyah of UC Law San Francisco. She described California’s CCRC framework, including entrance fee structures, monthly fee increases, contract types (A, B, and C), disclosure requirements, and regulatory oversight. A major theme was that residents often do not understand the contracts they sign, while providers retain broad discretion over fees, transfers, terminations, and changes to the physical plant. She also emphasized that California’s regulator is understaffed and not well suited to oversee the complex financial and insurance-like aspects of CCRCs, and that resident complaints and litigation can be slow and difficult. Choyah and commission members discussed several consumer-protection issues, including refundable versus repayable-on-resale entrance fees, rising monthly care fees, the decline of life care contracts, and the need for clearer disclosures and better comparative data for prospective residents. She noted that California requires annual disclosure statements, resident bill of rights materials, and some fee-related reporting, but that enforcement and accessibility remain weak. Members raised questions about resident board representation, accreditation, refund requirements, and whether state agencies or resident associations could help explain contracts to consumers before admission. Choyah suggested stronger oversight, more financial expertise in regulation, and better transparency about ownership and fee-setting. The meeting ended with discussion of the commission’s next steps toward its August report. Staff said a draft report would be prepared from the commission’s discussions and circulated for comment before final revisions. The chair also announced staff transitions: Jennifer would be leaving the State House role, and Juliana Fernandez and Vicky Halal would be the main contacts going forward. The commission adjourned after thanking Choyah for her presentation and answering member questions.

Transcript Highlights:

• Without accurate data, we lose sight of who is struggling to put food on the table.
• products, and data sets.
• Federal regulations require that health plans collect data and conduct comparative analysis to demonstrate
• The 2024 rules were a major step forward because they finally gave regulators clear...
• and data-driven tools to actually measure compliance.

Summary: The Senate Committee on Health heard presentations on several bills, beginning with AB 1734, which would expand California Health Interview Survey food insecurity data collection to households up to 400% of the federal poverty level. The author and supporters from food banks, AARP, county governments, and nutrition groups argued the bill would improve California’s ability to measure hunger amid federal cuts; there was no opposition. The committee also heard AB 1949, which would treat acupuncture as its own Medi-Cal benefit and allow up to 24 visits per year. Supporters said the current two-visits-per-month cap limits effective treatment and can increase reliance on medications; the bill drew broad support and no opposition. AB 1910, a postpartum pelvic floor health bill, was presented as an education and awareness measure encouraging patients to discuss pelvic floor concerns with providers, with no opposition. AB 2011 would codify federal mental health parity standards into state law; supporters said it would preserve enforcement if federal rules are rolled back, while insurers opposed it as premature given ongoing federal litigation and possible new rules. AB 2706 would modernize California’s cannery law to align with federal food safety standards and reduce duplicative requirements for food processors, with support from the dairy industry and no opposition. AB 2041 would require certain public safety agencies to report compliance with 911 dispatcher pre-arrival instruction training requirements, building on prior legislation; it also faced no opposition. After quorum was established, the committee voted on the bills. The consent calendar bills AB 1571, AB 1864, and AB 1956 were approved 6-0. AB 1734, AB 1910, AB 1949, AB 2041, and AB 2706 all passed the committee unanimously or near-unanimously and were re-referred to Appropriations or Education as applicable. AB 2011 passed 8-2, with some members expressing concern about federal litigation, implementation costs, and the timing of codifying the 2024 parity rule into state law. All bills were placed on call after the votes, and the committee adjourned after completing its agenda.

Transcript Highlights:

• And, you know, we talk about data centers, maybe... ...quickly.
• I regulate the entire site. However, I am regulated by the EPA. And I can tell you there...
• We're doing a lot with AI data center.
• You can use small modular reactors for a data center.
• with data centers, large light water reactors with data centers.

Summary: The meeting was an extended briefing from Idaho National Laboratory officials on the lab’s mission, its role in nuclear energy research, and the federal push to accelerate advanced reactor deployment. Speakers described INL’s size and capabilities, including test reactors, fuel and materials facilities, cybersecurity and critical infrastructure work, and partnerships with DOE, the NRC, the Department of Defense, and private companies. They emphasized that the lab is supporting both commercial nuclear development and national security work, while also training a large intern workforce. A major theme was the current federal effort to streamline nuclear regulation and speed up licensing and demonstration. The speakers said recent executive orders and DOE/NRC coordination are reducing redundant requirements, shortening environmental review timelines, and aiming for three new nuclear systems to reach criticality by July 4, 2026. They argued that regulatory uncertainty has been a major driver of nuclear cost and that the administration’s actions, along with DOE’s pilot and demonstration programs, are intended to rebuild the domestic supply chain and industrial base. The discussion also focused on advanced reactor types, including small modular reactors, microreactors, molten salt concepts, and liquid-metal designs. Officials said these technologies are being developed for data centers, military bases, remote communities, industrial heat, hydrogen production, and other nontraditional uses. They highlighted several projects and companies, including Oklo, Aalo, Radiant, X-energy, TerraPower, Kairos, and DOE’s MARVEL and Project Pele efforts, and said some reactors are expected to reach criticality or operation in the next few years. Questions from attendees covered safety, public health impacts, materials and heat management, waste or used fuel handling, costs, and whether nuclear could remain competitive against other energy sources; the speakers responded that advanced reactors are designed with passive safety features, that used fuel should be viewed as a resource, and that cost remains highly design- and supply-chain-dependent.

Transcript Highlights:

• Keenan: identifiable data. Question comes on adoption of the amendment.
• Montigny: health-connected data disclosure. Senator Montigny: Mr.
• Well, we make it consistent with those CHIA regulations.
• Well, we make it consistent with those CHIA regulations.
• This data is going to come from everywhere.

Keywords: 995, all

Summary: The Senate first adopted three congratulatory resolutions recognizing the retirements of Dolores Hayes, Lisa Audet, and Kate Fitzpatrick. It then handled several procedural matters, including suspending Joint Rule 12 to refer a sick leave bank bill for a Suffolk County Sheriff’s Office employee to the Committee on Public Service and referring House petitions to their respective committees. The chamber also adopted a conference report on the joint rules for the 2025-2026 session after remarks from Senators Creem, Tarr, Lovely, and Fattman emphasizing transparency, public access, recorded votes, longer notice for hearings and conference reports, remote participation, and periodic review of the rules. The report was accepted by a 40-0 roll call. The Senate then took up the bill strengthening health care protections in the Commonwealth, Senate No. 2538, commonly described as Shield Act 2.0. Senator Friedman and others argued the bill was needed to protect reproductive and gender-affirming care from out-of-state and federal interference, to limit disclosure of sensitive information, to create a state-level EMTALA-style protection for emergency care and active labor, and to strengthen privacy and licensing protections for providers and institutions. Senators Cyr, Lovely, and Fattman also spoke in support, framing the bill as a response to recent federal and state threats and as an extension of Massachusetts’ prior shield-law work. The chamber considered numerous amendments. Several were rejected, including amendments by Senators Finegold and Keenan and multiple Tarr amendments on topics such as medical records, consistency with existing law, and public health data collection. Some amendments were adopted, including a Montigny amendment on health-connected data disclosure, a Brownsberger amendment further protecting privacy for reproductive and gender-affirming care, a Rauch amendment clarifying protections for patients in active labor, a Tarr amendment removing an exemption for data from personal tracking devices, and a Rodrigues corrective amendment. After the amendments, the Ways and Means substitute was adopted, the bill was ordered to a third reading, and it then passed to be engrossed by a 37-3 roll call. At the end of the session, the Senate adopted a memorial adjournment in honor of former Senate Majority Leader Louis P. Bertinazi. The Governor also filed a message submitting a bill to build resilience for Massachusetts communities, authorizing future capital spending for energy and environmental affairs, which was referred to the Committee on Environment and Natural Resources. The Senate then adopted an order to meet again the following Monday at 1 p.m. and adjourned.

Transcript Highlights:

• </c> So again, we're going to get more regul So again, we're going to get more regul regulation<01:33
• c> it's</c><02:42:51.040><c> only</c><02:42:51.200><c> data</c> data collection because it's only data
• So we have plenty of data on this. There's all kinds of data on heat injuries.
• at accurate data.
• </c> we're not looking at accurate data. we're not looking at accurate data.

Keywords: 981, all

Transcript Highlights:

• So with that data, we've been using our data for the past three years with this bill pushing it forward
• So with that data, we've been using our data for the past three years with this bill pushing it forward
• I don't need to the FDA's data. I'm asking you.
• Let me interpret this data in plain language.
• They are regulated and they have required licenses.

Keywords: 995, all

Summary: The Joint Committee on Public Health heard testimony on a wide range of bills focused on environmental health, disease prevention, and access to care. Major topics included restricting polystyrene use, creating a pancreatic cancer awareness and early-detection initiative, improving indoor air quality through a task force and new regulations, expanding access to epinephrine in public places, improving access to health care for people with long COVID, creating an OBGYN loan repayment program for underserved areas, expanding access to hygiene products, modernizing licensure for dietitians and nutritionists, updating school postural screening requirements, and restricting harmful diet pills and muscle-building supplements. Several legislators also testified in support of their own bills, including measures on menstrual product access and ingredient disclosure, and surgical smoke protections. Testimony on the polystyrene bill emphasized local municipal bans and the need to reduce plastic pollution. Pancreatic cancer advocates and patients described the disease’s low survival rate, the difficulty of early diagnosis, and the need for an awareness campaign and implementation of commission recommendations. Indoor air quality supporters from environmental justice groups, public health organizations, and residents described asthma, mold, pollution, and the need for a task force with technical expertise; some witnesses urged adding remediation professionals to the task force. On epinephrine access, family members of a man who died after a bee sting and an allergy organization stressed that anaphylaxis can be sudden and fatal and that stock epinephrine in public venues could save lives. Long COVID advocates said the condition affects hundreds of thousands of residents and called for better surveillance and access to care, with a request to include MECFS in the bills’ scope. Other testimony focused on workforce and equity issues. Supporters of the OBGYN loan repayment bill said it would help address maternal health disparities and provider shortages, especially in rural and underserved communities. Hope and Comfort described widespread hygiene insecurity and a long waiting list for basic products, urging a task force to study statewide solutions. Dietitians and nutritionists supported modernization of licensure to clarify standards for medical nutrition therapy while allowing broader wellness counseling. School nurses backed reducing mandatory postural screenings, arguing the current law is not evidence-based, is not reimbursed by MassHealth, and takes time from other student health needs. On the supplement bill, the industry trade group opposed restrictions as overbroad and burdensome, while a public health expert cited research linking weight-loss and muscle-building supplements to serious harms and urged passage. The committee also heard support for menstrual product access and surgical smoke protections, with legislators and advocates describing those bills as longstanding priorities.